Related Experiment Video
Updated: Feb 11, 2026
07:04
A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
Published on: October 24, 2017
9.0K
[Psychotropic drugs in pregnancy]
Zsuzsa Valasinyovszki1, Alexander Kancsev
1Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktato Korhaz Pszichiatriai es Pszichoterapias Osztaly, Nyiregyhaza, Hungary,
Summary
Pregnant women increasingly use psychiatric medications. This review synthesizes literature on psychotropic drug safety during pregnancy to guide clinical decisions and minimize potential risks to mother and child.
Area of Science:
- Perinatal Psychiatry
- Reproductive Toxicology
- Clinical Pharmacology
Background:
- Increasing prevalence of pregnant women using psychotropic medications.
- Ethical constraints limit randomized controlled trials on psychiatric drug safety in pregnancy.
- Existing literature highlights potential risks of psychotropic drugs during gestation.
Purpose of the Study:
- To review reproductive safety data of psychiatric drugs.
- To provide clinical recommendations for pregnant psychiatric patients.
- To aid healthcare providers in managing psychotropic medication during pregnancy.
Main Methods:
- Comprehensive literature search on psychotropic medication use in pregnancy.
- Analysis of studies on teratogenicity, pregnancy outcomes, and neonatal effects.
- Synthesis of data regarding long-term developmental outcomes in offspring.
Main Results:
- Psychotropic drug use in pregnancy carries potential risks including teratogenicity, adverse pregnancy outcomes, neonatal complications, and withdrawal syndromes.
- Limited data exists on long-term neurodevelopmental and behavioral effects in children exposed to these medications in utero.
- Breastfeeding safety data for many psychotropic agents is also limited.
Conclusions:
- Informed clinical decision-making is crucial for pregnant women on psychiatric medication.
- Balancing maternal mental health needs with fetal safety requires careful consideration of available evidence.
- Further research is needed to fully understand the long-term impacts of psychotropic drug exposure during pregnancy.
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
462
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
462
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
165
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
165
01:26FDA Approved Drugs: Changes to Approved Drugs
275
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
275
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
262
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
262
01:27Factors Influencing Drug Absorption: Drug Dissolution
1.2K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.2K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
492
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
492